Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg

Currently, interferon add-on therapy brings hope for clinical cure of chronic hepatitis B patients with low HBsAg. However, in clinical practice patients with poor responses to their first interferon therapy were often switched to nucleos(t)ide analog therapy and then labeled as unsuitable patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaoan, Zhang, Ka, Xu, Qihuan, Shu, Xin, Mo, Zhishuo, Xie, Dongying, Gao, Zhiliang, Deng, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485616/
https://www.ncbi.nlm.nih.gov/pubmed/36148219
http://dx.doi.org/10.3389/fimmu.2022.997608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485616/
https://www.ncbi.nlm.nih.gov/pubmed/36148219
http://dx.doi.org/10.3389/fimmu.2022.997608

Ejemplares similares